BEHAVIOURAL OUTCOMES OF TREATMENT WITH CANNABIDIOL ORAL SOLUTION IN INDIVIDUALS WITH SEIZURES ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX: DESIGN OF AN ONGOING PHASE 4 TRIAL (EPICOM)

被引：0
|
作者：
van Eeghen, A. M. [1 ,2 ]
Thiele, E. A. [3 ]
Amin, S. [4 ]
Samanta, D. [5 ]
Stevens, J. [6 ]
Moore-Ramdin, L. [7 ]
de Vries, P. J. [8 ]
机构：
[1] Univ Amsterdam, Emma Childrens Hosp, Med Ctr, Amsterdam, Netherlands
[2] S Heeren Loo, Amersfoort, Netherlands
[3] Massachusetts Gen Hosp, Boston, MA USA
[4] Univ Hosp Bristol & Weston, Paediat Neurol, Bristol, Avon, England
[5] Univ Arkansas Med Sci, Dept Pediat, Child Neurol Sect, Little Rock, AR USA
[6] Jazz Pharmaceut Inc, Philadelphia, PA USA
[7] Jazz Pharmaceut Inc, Cambridge, England
[8] Univ Cape Town, Div Child & Adolescent Psychiat, Ctr Autism Res Africa, Cape Town, South Africa
来源：
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH | 2023年 / 67卷 / 09期
关键词：
Aberrant behaviour; Cannabidiol; Executive functioning; Neuropsychiatric disorders; Treatment-resistant seizures; Tuberous; sclerosis complex;
D O I：
暂无
中图分类号：
G76 [特殊教育];
学科分类号：
040109 ;
摘要：
引用
收藏
页码：812 / 812
页数：1
相关论文
共 34 条
  • [1] Behavioral outcomes of treatment with cannabidiol oral solution in individuals with seizures associated with tuberous sclerosis complex: Design of an ongoing phase 4 trial (EPICOM)
    Van Eeghen, Agnies
    Thiele, Elizabeth
    Amin, Sam
    Samanta, Debopam
    Stevens, Joanne
    Moore-Ramdin, Lisa
    De Vries, Petrus
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [2] Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trial
    Thiele, Elizabeth A.
    Bebin, E. Martina
    Filloux, Francis
    Kwan, Patrick
    Loftus, Rachael
    Sahebkar, Farhad
    Sparagana, Steven
    Wheless, James
    EPILEPSIA, 2022, 63 (02) : 426 - 439
  • [3] Add-On Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex A Placebo-Controlled Randomized Clinical Trial
    Thiele, Elizabeth A.
    Bebin, E. Martina
    Bhathal, Hari
    Jansen, Floor E.
    Kotulska, Katarzyna
    Lawson, John A.
    O'Callaghan, Finbar J.
    Wong, Michael
    Sahebkar, Farhad
    Checketts, Daniel
    Knappertz, Volker
    JAMA NEUROLOGY, 2021, 78 (03) : 285 - 292
  • [4] Long-term safety and efficacy of add-on cannabidiol for treatment of seizures associated with tuberous sclerosis complex in an open-label extension
    Kwan, Patrick
    Thiele, Elizabeth A.
    Bebin, E. Martina
    Filloux, Francis
    Jansen, Floor E.
    Loftus, Rachael
    Sahebkar, Farhad
    Sparagana, Steven
    Wheless, James
    EPILEPSIA, 2021, 62 : 145 - 146
  • [5] Outcomes in patients with tuberous sclerosis complex-associated treatment-refractory seizures, transitioning from placebo in core phase to everolimus during extension phase of the EXIST-3 trial
    French, J. A.
    Lawson, J. A.
    Yapici, Z.
    Ikeda, H.
    Polster, T.
    Nabbout, R.
    Curatolo, P.
    de Vries, P. J.
    Dlugos, D. J.
    Voi, M.
    Fan, J.
    Ridolfi, A.
    Pelov, D.
    Franz, D. N.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 87 - 87
  • [6] Adjunctive everolimus therapy for the treatment of refractory seizures associated with tuberous sclerosis complex: Results from a randomized, placebo-controlled, phase 3 trial
    French, Jacqueline
    Lawson, John A.
    Yapici, Zuhal
    Polster, Tilman
    Nabbout, Rima
    Curatolo, Paolo
    de Vries, Petrus J.
    Berkowitz, Noah
    Voi, Maurizio
    Peyrard, Severine
    Vaury, Alexandra
    Franz, David
    NEUROLOGY, 2016, 87 (02) : E23 - E24
  • [7] Efficacy and Safety of Add-on Cannabidiol (CBD) for Seizures Associated With Tuberous Sclerosis Complex (TSC) in Pediatric Patients Enrolled in a Phase 3 Trial With an Open-Label Extension (OLE)
    Thiele, E.
    Lawson, J.
    Kotulska, K.
    Sahebkar, F.
    Greco, T.
    Saurer, T.
    ANNALS OF NEUROLOGY, 2023, 94 : S57 - S57
  • [8] Adjunctive Everolimus Therapy for the Treatment of Refractory Seizures Associated with Tuberous Sclerosis Complex: Results from a Randomized, Placebo-Controlled, Phase 3 Trial
    French, Jacqueline A.
    Lawson, John A.
    Yapici, Zuhal
    Polster, Tilman
    Nabbout, Rima
    Curatolo, Paolo
    De Vries, Petrus J.
    Berkowitz, Noah
    Voi, Maurizio
    Pelov, Diana
    Peyrard, Severine
    Franz, David N.
    ANNALS OF NEUROLOGY, 2016, 80 : S32 - S32
  • [9] Efficacy and Safety of Add-on Cannabidiol (CBD) for Seizures Associated With Tuberous Sclerosis Complex (TSC) in Pediatric Patients Enrolled in a Phase 3 Trial With an Open-Label Extension (OLE)
    Thiele, E.
    Lawson, J.
    Kotulska, K.
    Sahebkar, F.
    Greco, T.
    Saurer, T.
    ANNALS OF NEUROLOGY, 2023, 94 : S55 - S55
  • [10] Adjunctive Everolimus Therapy for the Treatment of Refractory Seizures Associated With Tuberous Sclerosis Complex: Results From a Randomized, Placebo-Controlled, Phase 3 Trial
    Franz, D.
    Lawson, J.
    Nabbout, R.
    Curatolo, P.
    de Vries, P.
    Berkowitz, N.
    Voi, M.
    Peyrard, S.
    Vaury, A.
    French, J.
    Yapici, Z.
    ANNALS OF NEUROLOGY, 2016, 80 : S316 - S316
1234